The Union Health Ministry on Friday proposed easing residual shelf-life norms for imported drugs, requiring them to have a minimum remaining shelf life of 12 months at the time of import instead of the current threshold of more than 60% of total shelf life.
The proposal, published as a draft notification for public consultation on June 22, aims to promote ease of doing business while ensuring patients continue to receive quality medicines with adequate usable shelf life.
